Dow Up 0.15% Nasdaq Up 0.21%

ImmunoGen, Inc. (IMGN)

-NMS
11.30 Up 0.16(1.44%) Sep 17, 3:59PM EDT
Prev Close:11.14
Open:11.19
Bid:10.40 x 100
Ask:12.50 x 7800
1y Target Est:15.27
Beta:1.75
Earnings Date:Oct 23 - Oct 27 (Est.)
Day's Range:11.04 - 11.43
52wk Range:10.28 - 18.19
Volume:368,683
Avg Vol (3m):813,297
Market Cap:970.75M
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IMGNUp 1.44%970.75M
PFEUp 1.00%192.45B
RHHBYDown 0.31%253.89B
SGENDown 0.31%5.11B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.72
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback